Organisation paid for research Program year 2025 Source: CMS Open Payments

Ziaderm Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$245,332

136 payments

Through program year 2025, Ziaderm Research, LLC is reported as receiving $245,332 in research payments, across 136 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$232,983	108
2024	Research	$12,348	28

Breakdown

Who paid Research payments · program years 2024–2025

Incyte Corporation $244,149 109 payments
Daiichi Sankyo Inc. $1,183 27 payments

Studies the money was for Research payments · program years 2024–2025

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) $83,427 26 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa $78,603 43 payments
A study to evaluate the safety and tolerability of maximal use Ruxolitinib Cream $39,434 19 payments
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa $31,519 20 payments
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) $11,165 1 payment
Ds7011-107 $1,183 27 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.